Proton Therapy for Pediatric Hodgkin Lymphoma

ConclusionPT for PHL showed no short‐term severe toxicity and yields similar short‐term control to recently published large multi‐institutional clinical trials.

Source: Pediatric Blood and Cancer - May 2, 2016 Category: Cancer & Oncology Authors: Justin Wray, Stella Flampouri, William Slayton, Michael Joyce, Eric Sandler, Christopher G. Morris, Zuofeng Li, Daniel J. Indelicato, Nancy P. Mendenhall, Bradford S. Hoppe Tags: RESEARCH ARTICLE Source Type: research